Menu

Markets

Research

News

Learn
Paper trading
AI Chat
Get the app WatchlistsPortfoliosAlerts
Sign in

AgeX Therapeutics, Inc. AGE

Set alert

Price alert · AGE

All alert types
11.10 +11.10 —

Day range unavailable

52-week range unavailable

Open
—
Prev close
0.00
Mkt cap
27.76M
Vol
0
Avg vol
0
EPS
0.00
P/E
0.00
Div yield
0.00%
More statistics
Low
—
High
—
Forward P/E
0.00
Beta
1.19
Short ratio
3.88
Inst. own
0.00%
Dividend
0.00
Ex-div date
50-d avg
13.98
200-d avg
19.89
1y target
0.00

3M chart

Chart tools
Interval
1m5m15m30m

Events in this range
  • Mar 15, 2024Split: 1 for 35
Signals (28)
NameDateAgo
MACD: Sell SignalMar 21, 20242 years ago
SMA: BearishMar 20, 20242 years ago
SMA: BearishMar 20, 20242 years ago
RSI: OverboughtMar 15, 20242 years ago
SMA: BullishMar 12, 20242 years ago
SMA: BullishMar 12, 20242 years ago
MACD: Buy SignalMar 12, 20242 years ago
MACD: Sell SignalMar 11, 20242 years ago
SMA: BearishMar 7, 20242 years ago
SMA: BearishMar 6, 20242 years ago
SMA: BullishMar 4, 20242 years ago
SMA: BullishMar 4, 20242 years ago
MACD: Buy SignalMar 4, 20242 years ago
SMA: BearishFeb 21, 20242 years ago
SMA: BearishFeb 21, 20242 years ago
MACD: Sell SignalFeb 21, 20242 years ago
SMA: BullishFeb 20, 20242 years ago
SMA: BearishFeb 16, 20242 years ago
MACD: Buy SignalFeb 16, 20242 years ago
SMA: BullishFeb 15, 20242 years ago

Newest 20 of 28.

Financial health

Altman Z-Score

-3.07 Distress zone

Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.

Piotroski F-Score

3 / 9 Weak

Nine pass/fail tests of profitability, leverage and efficiency.

Valuation

P/E -5.8×
FY 2017: -14.8×FY 2018: -13.9×FY 2019: -5.5×FY 2020: -5.2×FY 2021: -4.0×FY 2022: -2.0×FY 2023: -1.0×FY 2024: -7.4×FY 2025: -5.8×
FY 2017 5y median -4.0× FY 2025
P/S 870×
FY 2017: 69.2×FY 2018: 74.8×FY 2019: 39.3×FY 2020: 30.7×FY 2021: 287×FY 2022: 616×FY 2023: 103×FY 2024: 1459×FY 2025: 870×
FY 2017 5y median 616× FY 2025
P/B -3057×
FY 2017: 13.3×FY 2018: 14.0×FY 2019: 30.6×FY 2020: -11.2×FY 2021: -3.5×FY 2022: -1.2×FY 2023: 2.7×FY 2024: 127×FY 2025: -3057×
FY 2017 5y median -1.2× FY 2025
P/FCF -6.3×
FY 2017: -15.4×FY 2018: -10.6×FY 2019: -6.3×FY 2020: -7.3×FY 2021: -5.3×FY 2022: -3.5×FY 2023: -1.9×FY 2024: -4.8×FY 2025: -6.3×
FY 2017 5y median -4.8× FY 2025
EV/EBITDA 1510×
FY 2017: -9.5×FY 2018: -9.1×FY 2019: -5.8×FY 2020: -7.2×FY 2021: -7.3×FY 2022: -5.4×FY 2023: -1.9×FY 2024: 404×FY 2025: 1510×
FY 2017 5y median -1.9× FY 2025
EV/Sales 848×
FY 2017: 63.9×FY 2018: 70.0×FY 2019: 39.0×FY 2020: 33.7×FY 2021: 374×FY 2022: 1130×FY 2023: 131×FY 2024: 1398×FY 2025: 848×
FY 2017 5y median 848× FY 2025
FCF Yield -15.9%
FY 2017: -6.5%FY 2018: -9.5%FY 2019: -15.9%FY 2020: -13.7%FY 2021: -19.0%FY 2022: -28.4%FY 2023: -53.4%FY 2024: -21.0%FY 2025: -15.9%
FY 2017 5y median -21.0% FY 2025

Profitability

Gross Margin 0.0%
FY 2017: 88.0%FY 2018: 73.9%FY 2019: 85.9%FY 2020: 91.5%FY 2021: 86.8%FY 2022: 61.8%FY 2023: -20.4%FY 2024: 0.0%FY 2025: 0.0%
FY 2017 5y median 0.0% FY 2025
Operating Margin -18478.5%
FY 2017: -474.6%FY 2018: -805.5%FY 2019: -726.8%FY 2020: -571.3%FY 2021: -5582.6%FY 2022: -20514.7%FY 2023: -7014.1%FY 2024: -30442.9%FY 2025: -18478.5%
FY 2017 5y median -18478.5% FY 2025
Net Margin -14950.8%
FY 2017: -468.7%FY 2018: -537.4%FY 2019: -716.7%FY 2020: -587.6%FY 2021: -7097.2%FY 2022: -31394.1%FY 2023: -10424.6%FY 2024: -19894.6%FY 2025: -14950.8%
FY 2017 5y median -14950.8% FY 2025
ROE 52529.7%
FY 2017: -90.4%FY 2018: -100.7%FY 2019: -558.3%FY 2020: 214.5%FY 2021: 86.4%FY 2022: 62.0%FY 2023: -270.7%FY 2024: -1738.1%FY 2025: 52529.7%
FY 2017 5y median 62.0% FY 2025
ROIC -708.4%
FY 2017: -58.4%FY 2018: -136.6%FY 2019: -274.6%FY 2020: -1092.0%FY 2021: -605.8%FY 2022: -862.2%FY 2023: -102.4%FY 2024: -391.2%FY 2025: -708.4%
FY 2017 5y median -605.8% FY 2025
ROA -279.6%
FY 2017: -68.3%FY 2018: -70.3%FY 2019: -166.4%FY 2020: -279.6%FY 2021: -324.0%FY 2022: -329.3%FY 2023: -123.7%FY 2024: -165.7%FY 2025: -279.6%
FY 2017 5y median -279.6% FY 2025

Growth (YoY)

Revenue 132.1%
FY 2017: 0.0%FY 2018: -0.6%FY 2019: 23.8%FY 2020: 8.1%FY 2021: -92.3%FY 2022: -76.4%FY 2023: 317.6%FY 2024: -60.6%FY 2025: 132.1%
FY 2017 FY 2025
Operating Income -40.9%
FY 2017: 0.0%FY 2018: -68.8%FY 2019: -11.7%FY 2020: 15.0%FY 2021: 24.7%FY 2022: 13.2%FY 2023: -42.8%FY 2024: -71.2%FY 2025: -40.9%
FY 2017 FY 2025
EPS (diluted) -26.5%
FY 2017: 0.0%FY 2018: -17.0%FY 2019: -54.6%FY 2020: 12.3%FY 2021: 7.4%FY 2022: -4.2%FY 2023: -38.7%FY 2024: 89.0%FY 2025: -26.5%
FY 2017 FY 2025
Free Cash Flow -4.6%
FY 2017: 0.0%FY 2018: -57.3%FY 2019: -9.2%FY 2020: 27.4%FY 2021: -0.2%FY 2022: 24.4%FY 2023: -31.3%FY 2024: -120.0%FY 2025: -4.6%
FY 2017 FY 2025

Financial Health

Current Ratio 1.7×
FY 2017: 5.8×FY 2018: 3.2×FY 2019: 1.2×FY 2020: 0.4×FY 2021: 0.2×FY 2022: 0.2×FY 2023: 0.1×FY 2024: 2.4×FY 2025: 1.7×
FY 2017 5y median 0.2× FY 2025
Quick Ratio 1.7×
FY 2017: 5.8×FY 2018: 3.2×FY 2019: 1.2×FY 2020: 0.4×FY 2021: 0.2×FY 2022: 0.2×FY 2023: 0.1×FY 2024: 2.4×FY 2025: 1.7×
FY 2017 5y median 0.2× FY 2025
Debt / Equity -5.3×
FY 2017: 0.0×FY 2018: 0.0×FY 2019: 0.9×FY 2020: -1.2×FY 2021: -1.1×FY 2022: -1.1×FY 2023: 0.8×FY 2024: 0.4×FY 2025: -5.3×
FY 2017 5y median -1.1× FY 2025
Net Debt / EBITDA -39.2×
FY 2017: 0.8×FY 2018: 0.6×FY 2019: 0.0×FY 2020: -0.7×FY 2021: -1.7×FY 2022: -2.5×FY 2023: -0.4×FY 2024: -17.5×FY 2025: -39.2×
FY 2017 5y median -2.5× FY 2025
Interest Coverage 113×
FY 2017: 0.0×FY 2018: -96.9×FY 2019: 0.0×FY 2020: 0.0×FY 2021: -7.3×FY 2022: -2.1×FY 2023: -2.0×FY 2024: 32.4×FY 2025: 113×
FY 2017 5y median -2.0× FY 2025

Dividends

Dividend Yield 0.0%
FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2017 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2017 5y median 0.0% FY 2025

Annual · latest fiscal year ends 2025-12-31